BOI:EPA
Boiron SA
€18.70
0.00%
(0.00) 1D
Oct 29, 5:35:14 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Mkt. cap
321.08M
Avg. vol.
6.91K
Volume
0.00
P/E ratio
12.40
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Mkt. cap
321.08M
Avg. vol.
6.91K
Volume
0.00
P/E ratio
12.40
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
شبكة تواصل الإخبارية
·
1 hour ago
Warren Buffett’s 90% S&P 500 Index Funds Advice Still Fits Long Horizons
TradingView
·
1 hour ago
IXIC: Nasdaq Futures Slide in Post-Earnings Selloff as AI Spending Fears Hit Global Tech
The Acquirer's Multiple
·
10 hours ago
S&P 500 Concentration Risk: Why Small-Cap and Mid-Cap Stocks Could Outperform
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA